Condensed Statement Of Cash Flows - USD ($)	3 Months Ended	4 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (55,850,310)	$ (55,860,934)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of derivative liabilities		893,835
Financing expense on derivative liabilities	54,956,475	54,956,475
Changes in operating assets and liabilities:
Accrued offering costs		10,624
Net cash used in operating activities
Cash flows from Financing activities:
Proceeds from issuance of promissory payable - related party		300,000
Proceeds from issuance of Class L ordinary shares to Sponsor		25,000
Payments of deferred offering costs included in accrued expenses		(319,220)
Prepaid stock subscription		9,750,000
Net cash provided by financing activities		9,755,780
Net change in cash and cash equivalents and restricted cash		9,755,780
Cash and cash equivalents and restricted cash, beginning of the period
Cash and cash equivalents and restricted cash, end of the period	$ 9,755,780	9,755,780
Supplemental disclosure of noncash activities:
Deferred offering costs		$ 578,141